Managed Healthcare

Federal funding disruptions are straining HIV programs nationwide. Kirk Grisham & Vishakh Unnikrishnan of the O’Neill Institute explain how delays, flat funding, and policy shifts are impacting care—and why state leadership now determines access. hubs.li/Q047DfR30

#PBMReform is accelerating. New #Medicare Part D rules, California’s fiduciary law and proposed federal legislation are raising questions about transparency and accountability. 👉 Join us for an expert discussion on April 7: hubs.li/Q047lKsm0 #ManagedCare #HealthcarePolicy

Recognition matters. Honor a healthcare professional whose leadership and ideas are influencing #ManagedCare today and tomorrow. Submit a nomination for #EmergingLeaders in Healthcare: hubs.li/Q045MVy40

Your perspective on treatment trends and pharmacy policy matters — and today is the last day to share it! By completing the survey, you will directly impact our industry coverage and be entered to win a $10 Amazon gift card. Start the Survey: hubs.li/Q046MJF40 #managedcare

Shorter hospital stays may signal value-based care is working. Jaewon Ryu says early results at Risant Health show improvements in care coordination quality and patient experience. More on the early findings: hubs.li/Q046MR3G0

Primary care may be the key to catching dementia earlier. Experts from Jefferson Health and Independence Blue Cross shared better screening and care coordination in primary care could help patients get support sooner. Learn more about the program here: hubs.li/Q046MLbM0

"The system is designed for episodic intervention—but then what happens?" CareOregon CEO Eric C. Hunter discusses the "out of control" challenge of substance use disorder and why dismantling social determinant programs is "penny-wise and pound-foolish." hubs.li/Q046B1TK0

Ipsen has withdrawn the cancer drug Tazverik (tazemetostat) from all markets because of a risk for secondary hematological malignancies hubs.li/Q046g3Yn0

Can rewards help those with HIV quit smoking? A news study in Substance Use and Addiction found higher short-term quit rates when nicotine replacement therapy was paired with a rewards-based program. Read more about the program and study here: hubs.li/Q0465zhp0

Now is your chance to contribute to our pharmacy survey! Weigh in on the biggest breakthroughs in treatment and pharmacy policy — complete the survey for a chance to win a $10 gift card. Start the Survey: hubs.li/Q04603CC0 #PharmacyPolicy #ManagedCare #HealthcareLeaders

"Earlier recognition and treatment of disease is what we're talking about when we talk about value-based care,” Jaewon Ryu, M.D., J.D., of Risant Health said, adding value-based models shift healthcare’s “center of gravity” upstream. Listen in for more: hubs.li/Q045WDSS0

Vakharia was in the inaugural class of our Emerging Leaders in Healthcare recognition program in 2017. We circled back to find out what he is up to. hubs.li/Q045NsCD0

Medicare coverage alone hasn’t closed racial gaps in lung cancer care. Recent data shows Black beneficiaries with early-stage NSCLC are still less likely to receive curative treatment, mainly due to lower surgery rates. Read for more detail at the below: hubs.li/Q045D9GR0

GLP-1 use is rising fast. But key questions remain. How long will patients stay on therapy? Can coverage stay sustainable? New reporting examines how persistence and cost are shaping payer decisions. Unlock the article: hubs.li/Q045CtnT0

As treatment options expand for patients with #BRAFV600E mutant metastatic #NSCLC, clinicians face new questions about sequencing and efficacy. Experts take a closer look at the data driving these decisions and what it means for real-world practice. hubs.li/Q045ryGc0

Brian Evanko to be Cigna CEO starting in July hubs.li/Q045qq0C0

Tomorrow at 12 PM EST. Politics. Policy. 2026. Healthcare is at a tipping point — are you ready? Register now. hubs.li/Q045g2910

AI is reducing documentation in managed care, but ROI and governance will decide long-term success. Ben Scharfe of Altera Digital Health explains what leaders should track in 2026, from burnout to transparency. Here’s what payers & providers need to know: hubs.li/Q045fqqJ0

Innovation in pharmacy benefits deserves recognition. #PBMI Innovators honors leaders transforming #PharmacyBenefitManagement through data, strategy, and measurable impact. Nominate an organization or individual now: hubs.li/Q0458DFQ0

Cell & gene therapy success takes more than science. Zahra Mahmoudjafari of The University of Kansas Cancer Center shares how hospitals can build sustainable programs under new CMS access rules—with strong workflows, pharmacy-finance alignment & more. hubs.li/Q04536Bw0